2020 Annual Meeting On-Demand Oral Presentations

View the oral presentations from the SGO 2020 Annual Meeting that were not part of the live webinar series in Spring 2020. 

  • A first in-human proof-of-concept trial of intravaginal artesunate to treat cervical - C. Trimble
  • Age matters when predicting overall survival benefit of chemoradiation vs. radiation
  • A high-depth multi-omics analysis of clinically defined subsets of high-grade serous ovarian cancer - A. Sood
  • Anti-tumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo - J. Ray
  • A Phase IB study of navicixizumab & weekly paclitaxel in heavily pre-treated platinum resistant ovarian, primary peritoneal or fallopian tube cancer - K Moore
  • A Phase IB Trial of Pacitaxel and Carboplatin + Galunisertib in Patients with Gynecologic Carcinosarcoma
  • A Phase III randomized controled trial of prophylactic negative pressure wound therapy in post-operative incision management
  • AVB-S6-500, a receptor tyrosine kinase AXL inhibitor, has improved therapeutic efficacy in combination with bevacizumab in uterine serous cancer - M. Toboni
  • Behavioral weight loss intervention effectiveness in gynecologic oncology clinics - A. Zamorano
  • Camrelizumab plus apatinib in patients with advanced cervical cancer - C Lan
  • Compensation differences in Gynecologic Oncology
  • Demicizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal
  • Increased physical activity promotes CD8+ lymphocyte infiltration and improves survival in a murine model of ovarian cancer - S. Lynam
  • Initial findings from a prospective, large scale patient reported outcomes program in patients with gynecologic malignancy - R. Sisodia
  • Laparoscopic Interval Debulking Surgery for Advanced Ovarian Cancer - Jorgensen
  • Less guessing, more evidence in identifying patients least fit for cytoreductive surgery - D. Narasimhulu
  • Modifying risk factors for anastomotic leak in gynecologic oncology surgery - V. Manzina
  • Multimodality algorithm to improve outcomes in patients receiving upfront surgical treatment for advanced ovarian cancer: a memorial sloan kettering team ovary initiative - A. Straubhar
  • Out-of-pocket costs for PARP Inhibitor Treatment
  • Perception and acceptability of human papillomavirus (HPV) vaccination among women presenting for cervical cancer (CxCA) screening in northern Tanzania - J. Maher
  • Preliminary Prospective Quality of Life and Clinical Outcomes using an Opiate Sparing Enhanced Recovery Protocol - Kuznicki
  • Relapse vs Chemotherapy Resistance after First-Line Single-Agent Chemotherapy in Patients with Low Risk Gestational Trophoblastic Neoplasia
  • Risk factors for unplanned readmission due to uncontrolled symptoms or minor complications after surgery for gynecologic cancer - A. Pyrzak
  • Same-day discharge for gynecologic oncology patients undergoing minimally invasive hysterectomy: Feasibility, safety, factors associated with admission and post-operative adverse events - A. Wield
  • The impact of frailty on readmission morbidity and mortality after surgery for endometrial cancer - T. Sia
  • Turning ProMisE into practice: Predicting response in medically managed endometrial cancers via molecular classification - A. Puechl
  • Understanding Mechanisms of Disparities in Gynecologic Malignancies
  • Universal Frontline PARP Maintenance: Just OK Is Not OK
  • Upfront maintenance with anti-vascular versus PARP inhibitors in advanced ovarian cancer: A cost-effective analysis - M. Richardson
  • Utilization of the emergency department by gynecologic oncology patients: high rates and high needs in a medically vulnerable population - D. Saris
  • Video-assisted genetic counseling in patients with ovarian, fallopian, and peritoneal carcinoma
  • Water only fasting and its effect on chemotherapy administration in gynecologic malignancies - C. Riedinger

Keywords: Allied health, Career development, Clinical trial, Clinical practice, Genetics, Telemedicine, Diversity & inclusion

Target Audience

Physicians, APPs, Trainees, Pharmacists, Residents, Fellows
Course summary
Course opens: 
Course expires: 


Please login or register to take this course.